ABINGDON HEALTH PLC Logo

ABINGDON HEALTH PLC

A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.

ABDX | IL

Overview

Corporate Details

ISIN(s):
GB00BLB79S77 (+2 more)
LEI:
213800XFI4WV3FBILO20
Country:
United Kingdom
Address:
YORK BIOTECH CAMPUS, YO41 1LZ YORK
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Abingdon Health PLC is a contract development and manufacturing organization (CDMO) specializing in lateral flow rapid tests. The company provides comprehensive, end-to-end services supporting clients from initial concept through to commercial success. Core offerings include assay development, scale-up, technical transfer, high-volume manufacturing, regulatory consultancy, and commercialization support. The company serves a diverse range of sectors, including clinical diagnostics, animal health, and plant health. In addition to its contract services, Abingdon Health also develops, manufactures, and distributes its own portfolio of branded lateral flow products to a global network of consumers, retailers, and distributors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-14 08:58
Share Issue/Capital Change
Launch of Retail Offer
English 50.1 KB
2025-10-14 08:47
Share Issue/Capital Change
Result of Placing and Notice of GM
English 30.1 KB
2025-10-13 18:04
Share Issue/Capital Change
Proposed Placing and Retail Offer
English 214.5 KB
2025-08-14 19:01
Director's Dealing
Director/PDMR Shareholding
English 26.1 KB
2025-08-05 08:00
Earnings Release
Trading update
English 24.6 KB
2025-07-31 08:00
Regulatory News Service
c. US$2.5m companion diagnostic test contract win
English 19.8 KB
2025-06-04 08:00
Board/Management Information
Update re. strategic partnership with FOFH
English 17.7 KB
2025-06-02 08:00
Regulatory News Service
Avian flu (H5N1) lateral flow test
English 23.7 KB
2025-03-17 08:00
Report Publication Announcement
Notice of Results
English 15.1 KB
2025-03-17 08:00
Regulatory News Service
Salistick™ to be launched in Germany
English 20.1 KB
2025-01-27 08:00
Regulatory News Service
Funding award to develop test for malaria parasite
English 20.1 KB
2025-01-08 08:00
Regulatory News Service
CS (Lifesciences) Ltd contract win
English 16.0 KB
2024-12-19 08:00
Board/Management Information
Directorate Change
English 25.3 KB
2024-12-17 08:09
Regulatory News Service
Abingdon Analytical Laboratory opens at Doncaster
English 16.9 KB
2024-12-17 08:00
Regulatory News Service
Contract win: sexually transmitted disease tests
English 17.8 KB

Automate Your Workflow. Get a real-time feed of all ABINGDON HEALTH PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ABINGDON HEALTH PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
KOA SHOJI HOLDINGS CO.,LTD. Logo
Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.
Japan 9273
KOBAYASHI PHARMACEUTICAL  CO.,LTD. Logo
Manufactures OTC pharma, personal care, and household goods for niche consumer markets.
Japan 4967
Kohjin Bio Co., Ltd. Logo
A CDMO providing culture media & bioservices for cell therapy, research, and diagnostics.
Japan 177A
KOLON LIFE SCIENCE Inc. Logo
Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.
South Korea 102940
Kolon TissueGene, Inc. Logo
Developing cell and gene therapies for orthopedic and degenerative disorders.
United States of America 950160
Develops animal health products and novel drugs for human cancer and autoimmune diseases.
South Korea 041960
KOREA ARLICO PHARM CO.,LTD. Logo
Manufactures generic drugs and provides CDMO services to a global market.
South Korea 260660
Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea 014570
K Pharma,Inc. Logo
Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.
Japan 4896
Kringle Pharma,Inc. Logo
Develops regenerative HGF medicines for rare and intractable neurological diseases.
Japan 4884

Talk to a Data Expert

Have a question? We'll get back to you promptly.